B. anthracis in a wool-processing factory: Seroprevalence and occupational risk

Epidemiology and Infection

Volumn 140, Issue 5, 2012, Pages 879-886

  Kissling, E ^a,b   Wattiau, P ^c   China, B ^a   Poncin, M ^d   Fretin, D ^c   Pirenne, Y ^e   Hanquet, G ^a,f  

^a SCIENTIFIC INSTITUTE OF PUBLIC HEALTH   (Belgium)

^b EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

^c VETERINARY AND AGROCHEMICAL RESEARCH CENTRE   (Belgium)

^d Occupational Doctor ^*  (Belgium)

^e Health Inspectorate   (Belgium)

^f independent environmental consultant at Easton Consult SPRL   (Belgium)

Author keywords

Anthrax; Bacillus anthracis; goat hair; occupational exposure; protective antigen; seroprevalence; wool; wool sorters

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY;

ADULT; ANTHRAX; ANTIBODY RESPONSE; ARTICLE; BACILLUS ANTHRACIS; BACTERIAL SPORE; BACTERIAL TRANSMISSION; CLINICAL FEATURE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GOAT; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HAZARD; RISK ASSESSMENT; RISK FACTOR; SEROCONVERSION; SEROPREVALENCE; TEXTILE INDUSTRY; WOOL;

ADULT; ANIMALS; ANTHRAX; ANTIBODIES, BACTERIAL; BACILLUS ANTHRACIS; BELGIUM; FEMALE; GOATS; HUMANS; MALE; MIDDLE AGED; OCCUPATIONAL EXPOSURE; RISK ASSESSMENT; SEROEPIDEMIOLOGIC STUDIES; WOOL;

EID: 84859422804     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268811001488     Document Type: Article

References (25)

1. Dewan PK, et al. Inhalational anthrax outbreak among postal workers, Washington, DC, 2001. Emerging Infectious Diseases 2002; 8: 1066-1072.
2. Bell JH, Fee E, Brown TM. Anthrax and the wool trade. 1902. American Journal of Public Health 2002; 92: 754-757.
3. Brachman PS, Fekety FR. Industrial anthrax. Annals of the New York Academy of Sciences 1958; 70: 574-584.
4. Bales ME, et al. Epidemiologic response to anthrax outbreaks: field investigations, 1950-2001. Emerging Infectious Diseases 2002; 8: 1163-1174. (Pubitemid 35257011)
5. Brachman PS, et al. An epidemic of inhalation anthrax: The first in the twentieth century. II. Epidemiology. American Journal of Hygiene 1960; 72: 6-23.
6. Pfisterer RM. An anthrax epidemic in Switzerland. Clinical, diagnostic and epidemiological aspects of a mostly forgotten disease [in German]. Schweizerische Medizinische Wochenschrift 1991; 121: 813-825.
7. Metcalfe N. The history of woolsorters' disease : A Yorkshire beginning with an international future ? Occupational Medicine 2004 54 489-493. (Pubitemid 39462226)
8. Anon. Probable human anthrax death in Scotland Eurosurveillance 2006 11 E060817 060812.
9. Anaraki S, et al. Investigations and control measures following a case of inhalation anthrax in East London in a drum maker and drummer, October 2008. Eurosurveillance 2008; 13.
10. Centers for Disease Control and Prevention (CDC). Cutaneous anthrax associated with drum making using goat hides from West Africa -Connecticut, 2007. Morbidity and Mortality Weekly Report 2008; 57: 628-631.
11. Norman PS, et al. Serologic testing for anthrax antibodies in workers in a goat hair processing mill. American Journal of Hygiene 1960; 72: 32-37.
12. Doolan DL, et al. The US capitol bioterrorism anthrax exposures: clinical epidemiological and immunological characteristics. Journal of Infectious Diseases 2007; 195: 174-184. (Pubitemid 46080049)
13. Wattiau P, et al. Occurrence and genetic diversity of Bacillus anthracis strains isolated in an active woolcleaning factory. Applied and Environmental Microbiology 2008; 74: 4005-4011. (Pubitemid 351962425)
14. Wattiau P, et al. Immunologic response of unvaccinated workers exposed to anthrax, Belgium. Emerging Infectious Diseases 2009; 15: 1637-1640.
15. Biagini RE, et al. Determination of serum IgG antibodies to Bacillus anthracis protective antigen in environmental sampling workers using a fluorescent covalent microsphere immunoassay. Occupational and Environmental Medicine 2004; 61: 703-708. (Pubitemid 38998114)
16. Hadler JL. Learning from the 2001 anthrax attacks : immunological characteristics. The Journal of Infectious Diseases 2007; 195: 163-164. (Pubitemid 46080045)
17. Dahlgren CM, et al. Bacillus anthracis aerosols in goat hair processing mills. American Journal of Hygiene 1960; 72: 24-31.
18. Fennelly KP, et al. Airborne infection with Bacillus anthracis -from mills to mail. Emerging Infectious Diseases 2004; 10: 996-1002.
19. Communicable Disease Center. Inhalation anthrax -Delaware County, Pennsylvania. Morbidity and Mortality Weekly Report 1961; 10: 2.
20. Sanderson WT, et al. Bacillus anthracis contamination and inhalational anthrax in a mail processing and distribution center. Journal of Applied Microbiology 2004; 96: 1048-1056. (Pubitemid 38582151)
21. Grunow R, et al. Monitoring of ELISA-reactive antibodies against anthrax protective antigen (PA), lethal factor (LF), and toxin-neutralising antibodies in serum of individuals vaccinated against anthrax with the PA-based UK anthrax vaccine. Vaccine 2007; 25: 3679-3683. (Pubitemid 46584757)
22. Quinn CP, et al. Immune responses to Bacillus anthracis protective antigen in patients with bioterrorism-related cutaneous or inhalation anthrax. Journal of Infectious Diseases 2004; 190: 1228-1236. (Pubitemid 39287748)
23. Abboud N, Casadevall A. Immunogenicity of Bacillus anthracis protective antigen domains and efficacy of elicited antibody responses depend on host genetic background. Clinical and Vaccine Immunology 2008; 15: 1115-1123. (Pubitemid 352018319)
24. Swartz MN. Recognition and management of anthrax -an update. New England Journal of Medicine 2001; 345: 1621-1626.
25. Van den Enden E, Van Gompel A, Van Esbroeck M. Cutaneous anthrax, Belgian traveler. Emerging Infectious Diseases 2006; 12: 523-525.